Filter

801 - 810 of 981 Results

  • Section 1115 Waiver Watch: Medicaid Pre-Release Services for People Who Are Incarcerated

    Issue Brief

    In April 2023, the Centers for Medicare and Medicaid Services (CMS) released guidance encouraging states to apply for a new Section 1115 demonstration opportunity to test transition-related strategies to support community reentry for people who are incarcerated. As of August 19, 2024, CMS has approved Section 1115 reentry waiver requests from 11 states, while 13 additional reentry waivers remain pending.

  • New KFF Focus Groups Reveal Medicaid Enrollee Experiences During Unwinding

    News Release

    Over six months after the expiration of pandemic-era enrollment protections, at least 27 million Medicaid enrollees—or roughly one-in-three enrollees across the country—have completed their state’s eligibility renewal process for the program. Over 18 million people have had their coverage renewed and over 10 million have been disenrolled, as of November 8, 2023.

  • A Look at Navigating the Health Care System: Medicaid Consumer Perspectives

    Issue Brief

    This brief gauges Medicaid enrollees’ perspectives on their health insurance, based on findings from KFF’s Survey of Consumer Experiences with Health Insurance, fielded February 21 through March 14, 2023. This brief provides an overview of the survey findings, describes Medicaid enrollees’ views of their health and health coverage, explores problems those with Medicaid experience, compares how Medicaid performs relative to Medicare and private coverage, and reviews variation in Medicaid experiences.

  • 10 Things to Know About the Unwinding of the Medicaid Continuous Enrollment Provision

    Issue Brief

    Medicaid enrollment increased since the start of the pandemic, primarily due to the continuous enrollment provision.KFF estimates that between 8 million and 24 million people will lose Medicaid coverage during the unwinding of the continuous enrollment provision.The Medicaid continuous enrollment provision stopped “churn” among Medicaid enrollees.States approaches to unwinding the continuous enrollment provision vary.

  • Medicaid: What to Watch in 2023

    Issue Brief

    As 2023 kicks off, a number of issues are at play that could affect coverage and financing under Medicaid. This issue brief examines key issues to watch in Medicaid in the year ahead.

  • A Look at Substance Use and Mental Health Treatment Facilities Across the U.S.

    Issue Brief

    This brief uses 2022 data from the National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual survey sent to all substance use and mental health treatment facilities to assess the supply and characteristics of these facilities at a national and state level. Despite the escalation of mental health needs and the increasing and evolving opioid epidemic, accessing treatment continues to be difficult--as indicated by consumer surveys and national data. Factors like the decline in psychiatric beds, financing barriers, difficulty accessing outpatient treatment, and the growing workforce shortages have led to more reports of unmet need and psychiatric boarding in emergency departments. Overall, there are approximately 14,700 facilities providing substance use treatment services and about 9,500 facilities that offer mental health services. More than eight in ten substance use treatment facilities and mental health facilities provide outpatient services; smaller shares offers more intensive inpatient services. Substance use treatment and mental health bed availability varies across states. Most substance use and mental health treatment facilities are non-profit; however, for-profit ownership is more common among substance use treatment facilities, whereas public ownership is more common among mental health facilities. Most facilities report high participation with private insurance and Medicaid, but lower for Medicare and there is variation across states. Reported Medicaid participation by substance use treatment facilities varies across states.